U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C12H17NO2
Molecular Weight 207.2689
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of EDMA

SMILES

CNC(C)CC1=CC=C2OCCOC2=C1

InChI

InChIKey=UJKWLAZYSLJTKA-UHFFFAOYSA-N
InChI=1S/C12H17NO2/c1-9(13-2)7-10-3-4-11-12(8-10)15-6-5-14-11/h3-4,8-9,13H,5-7H2,1-2H3

HIDE SMILES / InChI
Molecular Formula C12H17NO2
Molecular Weight 207.2689
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

Unknown
149124
Targets

Targets

Primary TargetPharmacologyConditionPotency
Inhibitor
8504
 117.0 nM [EC50]
Inhibitor
8504
 325.0 nM [EC50]
PubMed

PubMed

TitleDatePubMed
Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrine.
2015-09-01
Substance Class Chemical
Created
by admin
on Mon Mar 31 23:23:54 GMT 2025
Edited
by admin
on Mon Mar 31 23:23:54 GMT 2025
Record UNII
UJ7UU2C6E6
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
(±)-EDMA
Preferred Name English
EDMA
Common Name English
1-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-N-METHYLPROPAN-2-AMINE
Systematic Name English
ETHYLENEDIOXYMETHYLAMPHETAMINE
Systematic Name English
1,4-BENZODIOXIN-6-ETHANAMINE, 2,3-DIHYDRO-N,.ALPHA.-DIMETHYL-
Systematic Name English
3,4-ETHYLENEDIOXY-N-METHYLAMPHETAMINE
Systematic Name English
Classification Tree Code System Code
WIKIPEDIA Designer-drugs-EDMA
Created by admin on Mon Mar 31 23:23:54 GMT 2025 , Edited by admin on Mon Mar 31 23:23:54 GMT 2025
Code System Code Type Description
CAS
133787-66-3
Created by admin on Mon Mar 31 23:23:54 GMT 2025 , Edited by admin on Mon Mar 31 23:23:54 GMT 2025
PRIMARY
PUBCHEM
24257269
Created by admin on Mon Mar 31 23:23:54 GMT 2025 , Edited by admin on Mon Mar 31 23:23:54 GMT 2025
PRIMARY
FDA UNII
UJ7UU2C6E6
Created by admin on Mon Mar 31 23:23:54 GMT 2025 , Edited by admin on Mon Mar 31 23:23:54 GMT 2025
PRIMARY
EPA CompTox
DTXSID501027143
Created by admin on Mon Mar 31 23:23:54 GMT 2025 , Edited by admin on Mon Mar 31 23:23:54 GMT 2025
PRIMARY
WIKIPEDIA
EDMA
Created by admin on Mon Mar 31 23:23:54 GMT 2025 , Edited by admin on Mon Mar 31 23:23:54 GMT 2025
PRIMARY 3,4-Ethylenedioxy-N-methylamphetamine (EDMA) is an entactogen drug of the amphetamine class. It is an analogue of MDMA where the methylenedioxy ring has been replaced by an ethylenedioxy ring. EDMA was first synthesized by Alexander Shulgin.[1] In his book PiHKAL, the dosage is listed as 150?250 mg, and the duration listed as 3?5 hours. According to Shulgin, EDMA produces a bare threshold consisting of paresthesia, nystagmus, and hypnogogic imagery, with few to no other effects.
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966